SEC Form D · filed May 5, 2022
Pharmaceutics International, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
James E. Gale · Hunt Valley, MDDirectorJohn I. Guthrie · Hunt Valley, MDExecMichael E. Bogda · Hunt Valley, MDDirectorSana I. Abidi · Hunt Valley, MDDirectorJohn E. Fowler · Hunt Valley, MDExec · DirectorDavid E. Solomon · Hunt Valley, MDDirectorSyed E. Abidi · Hunt Valley, MDDirectorTimothy M. Barns · Boston, MADirectorThomas Lapham · Kirkland, WADirectorViva F. Hyatt · Boston, MADirectorJonathan J. Desimone · Boston, MADirectorJonathan Macey · Kirkland, WADirectorAndrew B. Clark · Toronto, Ontario, CanadaExec · DirectorHabib L. Kairouz · New York, NYExecAndrew J. Carlino · Boston, MADirectorJeffrey F. Robinson · Boston, MADirectorBrian F. Hirschfeld · Boston, MADirectorHugues J. De Braucourt · New York, NYExecRick H. Hurd · CHICAGO, ILDirectorErin H. Ankin · CHICAGO, ILDirectorJay Kahn · San Francisco, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗